The American Heart Association (AHA) claims there is no scientific evidence to demonstrate any benefit from EDTA chelation. Are they wrong?
A. Yes, they are. The AHA has declared that EDTA chelation is an “unproven treatment.” As we mentioned above, there are as many as 10,000 scientific papers supporting its use in many different areas. The primary articles the AHA and other establishment medical organizations rely on to “debunk” EDTA use are two Danish studies1,2 and a New Zealand study3 purporting to show that EDTA chelation was no better than a placebo for treating peripheral vascular disease of the legs. What the AHA fails to point out is that the Danish studies 1) provided insufficient treatment for the patient population selected, and 2) were condemned by the Danish Committee for Investigation into Scientific Dishonesty because of improper randomization and double-blinding, as well as for premature breaking of the blinding code. The Committee indicated that these practices amounted to deliberate bias on the part of the researchers. The New Zealand study also had severe methodological flaws: 1) It used a placebo cont
Related Questions
- Are these DHHS recommendations different from the earlier recommendations of the American Heart Association (AHA) and the American College of Cardiology (ACC)?
- Do ASHI training programs follow the 2005 American Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care?
- What’s the American Heart Association (AHA) position on placement of AEDs?
